A-share subscription | High-end scientific instrument developer Guoyi Company (688828.SH) opens subscription and is expected to change from loss to profit in 2026

The Zhitong Finance App learned that on July 31, Guoyi Company (688828.SH) began the subscription. The issuance price was 21.22 yuan/share, and the subscription limit was 60,000 shares. It belongs to the Shanghai Stock Exchange, and Huatai United Securities is its sponsor.

According to the prospectus, Guoyi Company focuses on the research and development of high-end scientific instruments, targeting various fields such as quantum technology, materials science, chemistry, biomedicine, advanced manufacturing, etc., to provide universities, research institutes, and enterprises around the world with high-end scientific instruments and equipment needed for cutting-edge exploration, and core key devices and solutions represented by enhanced quantum sensors.

Since its establishment, the company has successively launched a series of products such as electron paramagnetic resonance spectrometers, scanning NV probe microscopes, field emission scanning electron microscopes, and focused ion beam electron beam double beam microscopes. At the same time, the company is an explorer and application of quantum technology. The measurement sensitivity, accuracy, resolution and imaging capabilities of quantum information technology series products such as quantum diamond single spin spectrometers and wide-field NV microscopes based on NV color center sensors and optical magnetic resonance technology far exceed traditional measurement technology.

According to reports, Guoyi Company products have been delivered to more than 80 985/211 universities and more than 150 research institutes. Representative universities and research institutes include Tsinghua University, Peking University, China University of Science and Technology, Zhejiang University, Shanghai Jiao Tong University, Fudan University, Tongji University, Sun Yat-sen University, Nanjing University, Harbin Institute of Technology, Xi'an Jiaotong University, Cornell University, Oxford University, Columbia University, Singapore National University, Nanyang Technological University, University of Melbourne, Waterloo University, Seoul University, Chinese Academy of Sciences, China Institute of Engineering Physics, China Atomic Energy Science Representative corporate clients such as the Research Institute, the Chinese Academy of Metrology, and the Chinese Academy of Agricultural Sciences include BOE, BYD, Ningde Times, Chery Automobile, Longji Green Energy, Chengfei Group, China Southern Airlines, China Nuclear Power Group, China Telecom, CNPC, and CNOOC.

According to the research institute SDI, the global market size of the experimental analytical instrument industry is US$82.95 billion (approximately RMB 588.94 billion) in 2024. The market size is expected to increase to about US$101.58 billion (approximately RMB 721.22 billion) by 2029, with an average annual growth rate of 4.10% over the next five years. The global scientific instrument market is showing a steady and positive growth trend, and future development can be expected.

According to SDI data, the compound growth rate of China's experimental analytical instruments market share is expected to reach 4.7% from 2024-2029, ranking second among the world's major economies. By 2029, China's experimental analytical instrument market share can reach 11.66 billion US dollars (approximately RMB 82.79 billion). As the country's R&D funding continues to grow and enterprises continue to pay attention to R&D activities, China's demand for scientific instruments will continue to grow strongly.

As China's emphasis on basic scientific research has continued to increase in recent years, the construction of research institutes, universities, and industrial laboratories has progressed steadily, and the scale of investment in science and technology in the field of research and experiments has grown rapidly. According to data from the National Bureau of Statistics, in 2020, China's total investment in research and experimental development was 2,4393 billion yuan. By 2025, it had grown to 3,926.2 billion yuan, with a compound annual growth rate of 12.14%. Among them, basic research funding increased from 15.4 billion yuan in 2020 to over 300 billion yuan in 2025, with a compound annual growth rate of over 14.8%, accounting for 7.08% of the country's research and experimental development. The basic conditions for scientific research continued to improve. As a key equipment for obtaining experimental data and analyzing experimental results in the field of scientific research, the total amount and rapidly growing investment has accelerated the development of scientific research activities and boomed the scientific instrument market, especially experimental analytical instruments.

On the financial side, in 2023, 2024, and 2025, the company achieved operating income of about 340 million yuan, 501 million yuan, and 666 million yuan respectively; in the same period, it recorded net profit of about -146 million yuan, -86,1881 million yuan, and -5.8487 million yuan, respectively. Based on reasonable expectations for future major product sales, sales prices, operating costs, and the level of expenses for the period, the company expects the earliest point of turning loss into profit in 2026.